A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin

Archives of Iranian Medicine

Volumn 10, Issue 2, 2007, Pages 261-263

  Ansarin, Habib ^a   Tajziehchi, Leila ^a   Shaianfar, Nasrin ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidermodysplasia verruciformis; Squamous cell carcinoma; Sun exposure

Indexed keywords

ETRETIN;

ADULT; ARTICLE; CASE REPORT; EPIDERMODYSPLASIA VERRUCIFORMIS; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; IRAN; MALE; PHYSICAL EXAMINATION; REMISSION; SKIN BIOPSY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TINEA VERSICOLOR; VERRUCA VULGARIS;

ACITRETIN; ADULT; CARCINOMA, SQUAMOUS CELL; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; KERATOLYTIC AGENTS; MALE; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 34247609884     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sterling JC. Virus infections, In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. 7th ed. Oxford: Blackwell Science; 2004.
2. Gubinelli E, Posteraro P, Cocuroccia B, Girolomoni G. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin, J Dermatolog Treat. 2003; 14: 184-188.
3. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with EV, a disease induced by specific human papillomaviruses. J Invest Dermatol. 1984; 83 (suppl 1): 18-25.
4. Partridge ME, Pariser RJ. Ocular and cutaneous squamous cell carcinoma in an African American man with epidermodysplasia verruciformis resulting in blindness and death, J Am Acad Dermatol. 2003; 49 (suppl 5): 262-264.
5. Termorshuizen F, Feltkamp MC, Struijk L, de Gruijl FR, Bavinck JN, van Loveren H. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus, J Invest Dermatol. 2004; 122: 1456-1462.
6. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res. 2003; 63: 2695-2700.
7. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, Ploner M, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol. 2003; 139: 890-894.
8. Anadolu R, Oskay T, Erdem C, Boyvat A, Terzi E, Gurgey E. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. J Am Acad Dermatol. 2001; 45: 296-299.
9. Pereira de Oliveira WR, Carrasco S, Neto CF, Rady P, Tyring SK. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol. 2003; 30: 203-209.
10. Gross C, Basten D, Langner C. Squamous cell carcinoma developing from epidermodysplasia verruciformis [in German]. Pathologe. 1999; 20: 120-124.